Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 89 citing articles:

Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
Henry Jay Forman, Hongqiao Zhang
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 689-709
Open Access | Times Cited: 1911
Nrf2/Keap1/ARE signaling: Towards specific regulation
A. V. Ulasov, Andrey A. Rosenkranz, Georgii P. Georgiev, et al.
Life Sciences (2021) Vol. 291, pp. 120111-120111
Open Access | Times Cited: 329
Canonical and non-canonical mechanisms of Nrf2 activation
Carlos Alfredo Silva‐Islas, Perla D. Maldonado
Pharmacological Research (2018) Vol. 134, pp. 92-99
Closed Access | Times Cited: 313
Understanding mechanisms of antioxidant action in health and disease
Barry Halliwell
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 1, pp. 13-33
Closed Access | Times Cited: 247
Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome
Takumi Satoh, Dorit Trudler, Chang-ki Oh, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 124-124
Open Access | Times Cited: 92
Potential Applications of NRF2 Modulators in Cancer Therapy
Emiliano Panieri, Aleksandra Buha Djordjević, Pelin Telkoparan‐Akillilar, et al.
Antioxidants (2020) Vol. 9, Iss. 3, pp. 193-193
Open Access | Times Cited: 132
The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones
Matheus de Freitas Silva, Letizia Pruccoli, Fabiana Morroni, et al.
Molecules (2018) Vol. 23, Iss. 7, pp. 1803-1803
Open Access | Times Cited: 103
Terpenoids as Potential Geroprotectors
Ekaterina Proshkina, Sergey Plyusnin, Tatyana Babak, et al.
Antioxidants (2020) Vol. 9, Iss. 6, pp. 529-529
Open Access | Times Cited: 99
Can the emerging field of immunometabolism provide insights into neuroinflammation?
Marina A. Lynch
Progress in Neurobiology (2019) Vol. 184, pp. 101719-101719
Closed Access | Times Cited: 82
Nrf2: The Master and Captain of Beta Cell Fate
Sharon Baumel-Alterzon, Liora S. Katz, Gabriel Brill, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 32, Iss. 1, pp. 7-19
Open Access | Times Cited: 79
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
Jean Bousquet, Jean‐Paul Cristol, Heather J. Zar, et al.
Clinical and Translational Allergy (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 71
Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
Bora Tastan, Burak I. Ariöz, Şermin Genç
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 30
The Complex Genetic and Epigenetic Regulation of the Nrf2 Pathways: A Review
Joe M. McCord, Bifeng Gao, Brooks M. Hybertson
Antioxidants (2023) Vol. 12, Iss. 2, pp. 366-366
Open Access | Times Cited: 26
Natural Allies for Heart Health: Nrf2 Activation and Cardiovascular Disease Management
Safir Ullah Khan, Shahid Ullah Khan, Muhammad Suleman, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 1, pp. 102084-102084
Open Access | Times Cited: 23
Potential use of antioxidants for the treatment of chronic inflammatory diseases
Alexander V. Blagov, Volha I. Summerhill, Vasily N. Sukhorukov, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 16
Targeting KEAP1-mediated IKKβ degradation strategy for colitis-associated colorectal carcinogenesis: The potential of xanthohumol
Young‐Min Han, Sun‐Mi Yun, Da-Young Lee, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117879-117879
Open Access | Times Cited: 1
diAcCA, a Pro-Drug for Carnosic Acid That Activates the Nrf2 Transcriptional Pathway, Shows Efficacy in the 5xFAD Transgenic Mouse Model of Alzheimer’s Disease
Piu Banerjee, Yubo Wang, Lauren N. Carnevale, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 293-293
Open Access | Times Cited: 1
Nrf2 as a therapeutic target for rheumatic diseases
Marı́a Luisa Ferrándiz, Josep Nácher-Juan, María José Alcaraz
Biochemical Pharmacology (2018) Vol. 152, pp. 338-346
Open Access | Times Cited: 64
Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity
Valerio Azzimato, Ping Chen, Emelie Barreby, et al.
Gastroenterology (2021) Vol. 161, Iss. 6, pp. 1982-1997.e11
Open Access | Times Cited: 50
Multi-Target Effects of ß-Caryophyllene and Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and Neurodegeneration: From Oxidative Stress to Microglia-Mediated Neuroinflammation
Roberto Iorio, Giuseppe Celenza, Sabrina Petricca
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1199-1199
Open Access | Times Cited: 34
Brain Fog: a Narrative Review of the Most Common Mysterious Cognitive Disorder in COVID-19
Mahsa Aghajani Mir
Molecular Neurobiology (2023) Vol. 61, Iss. 12, pp. 9915-9926
Closed Access | Times Cited: 22
Crosstalk between Nrf2 signaling pathway and inflammation in ischemic stroke: Mechanisms of action and therapeutic implications
Negar Khassafi, Abolfazl Azami Tameh, Hamed Mirzaei, et al.
Experimental Neurology (2023) Vol. 373, pp. 114655-114655
Closed Access | Times Cited: 21
Curcumin improves exercise performance of mice with coronary artery ligation-induced HFrEF: Nrf2 and antioxidant mechanisms in skeletal muscle
Ahmed M. Wafi, Juan Hong, Tara Rudebush, et al.
Journal of Applied Physiology (2018) Vol. 126, Iss. 2, pp. 477-486
Open Access | Times Cited: 50
Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein–Protein Interaction
Yong Zhang, Zeyu Shi, Yujun Zhou, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 15, pp. 7986-8002
Closed Access | Times Cited: 50
Page 1 - Next Page

Scroll to top